scorecardresearch
Sunday, August 17, 2025
TopicMankind Pharma

Topic: Mankind Pharma

Income tax dept searches Mankind Pharma’s office in Delhi, CNBC TV18 reports

The company's shares fell as much as 5.5% on the news, which comes days after the condom maker listed on exchanges with sharp gains.

Mankind Pharma eyes $5 billion valuation in IPO

The IPO for the company will consist of nearly 40.1 million shares on offer for sale from existing shareholders, according to a prospectus.

Mankind Pharma receives DRDO license to manufacture, market Covid drug 2-DG

Drugs Controller General of India (DCGI) had permitted the emergency use of 2-DG on 1 May, as an adjunct treatment for moderate to severe Covid-19 patients.

On Camera

China wants to create new order in Myanmar. India must switch gears or be dealt out of the game

India’s policy on Myanmar has been to deal with its Generals and maintain a distance from the country’s insurgent groups and political struggles. This will have to change.

Modi’s ‘Diwali bonanza’ for the common man—next-gen GST reforms, lower tax on daily-use items soon

Finance ministry says the proposed revamp will focus on structural reforms, rate rationalisation & ease of living, & will be deliberated upon in the coming weeks.

What is Project Sudarshan Chakra, announced by Modi from ramparts of Red Fort

The project is meant to be a ‘protective shield that will keep expanding’, the PM said. It is on the lines of the ‘Golden Dome’ announced by Trump, it is learnt.

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?